EpiCast Report: Cystic Fibrosis – Epidemiology Forecast to 2025

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

2.1 Related Reports

2.2 Upcoming Reports

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.3 Global Trends

3.3.1 Diagnosed Incidence and Diagnosed Prevalence

3.4 Forecast Methodology

3.4.1 Sources Used

3.4.2 Forecast Assumptions and Methods

3.4.3 Sources Not Used

3.5 Epidemiological Forecast for CF (2015–2025)

3.5.1 Diagnosed Incident Cases, Based on Registry Data

3.5.2 Diagnosed Prevalent Cases, Based on Registry Data

3.5.3 CF Mortality, Based on Registry Data

3.5.4 Diagnosed Incident Cases, Adjusted for Underestimation

3.5.5 Diagnosed Prevalent Cases, Adjusted for Underestimation

3.5.6 CF Mortality, Adjusted for Underestimation

3.6 Discussion

3.6.1 Epidemiological Forecast Insight

3.6.2 Limitations of the Analysis

3.6.3 Strengths of the Analysis

4 Appendix

4.1 Bibliography

4.2 Physicians and Specialists Included in this Study

4.3 High-Prescribing Physician Survey

4.4 About the Authors

4.4.1 Epidemiologist

4.4.2 Reviewers

4.4.3 Global Director of Therapy Analysis and Epidemiology

4.4.4 Global Head of Healthcare

4.5 About GlobalData

4.6 About EpiCast

4.7 Contact Us

4.8 Disclaimer

Table 1: Risk Factors and Comorbidities of CF

Table 2: 7MM, Sources Used to Forecast the Diagnosed Incident Cases of CF (Based on Registry Data)

Table 3: 7MM, Sources Used to Forecast the Diagnosed Prevalent Cases of CF (Based on Registry Data)

Table 4: 7MM, Sources Used for Segmentation of Diagnosed Prevalent Cases of CF by Specific Mutations (Based on Registry Data)

Table 5: 7MM, Sources Used to Forecast the Proportion of Diagnosed Prevalent Cases of CF by Chronic MRSA Infection (Based on Registry Data)

Table 6: 7MM, Sources Used to Forecast CF Deaths (Based on Registry Data)

Table 7: 7MM, Proportion of CF Cases Reported to Respective CF Registries (Primary Research)

Table 8: 7MM, Sources Not Used in the Epidemiological Analysis of CF

Table 9: 7MM, Diagnosed Incident Cases of CF, All Ages, Both Sexes, N, Selected Years 2015–2025 (Based on Registry Data)

Table 10: 7MM, Sex-Specific Diagnosed Incident Cases of CF, All Ages, N (Row %), 2015 (Based on Registry Data)

Table 11: 7MM, Diagnosed Prevalent Cases of CF, All Ages, Both Sexes, N, Selected Years 2015–2025 (Based on Registry Data)

Table 12: 7MM, Age-Specific Diagnosed Prevalent Cases of CF, Both Sexes, N (Row %), 2015 (Based on Registry Data)

Table 13: 7MM, Sex-Specific Diagnosed Prevalent Cases of CF, All Ages, N (Row %), 2015 (Based on Registry Data)

Table 14: 7MM, Diagnosed Prevalent Cases of CF with Chronic MRSA Infection, All Ages, Both Sexes, N, Selected Years 2015–2025 (Based on Registry Data)

Table 15: 7MM, CF Deaths, All Ages, Both Sexes, N, Selected Years 2015–2025 (Based on Registry Data)

Table 16: 7MM, Sex-Specific CF Deaths, All Ages, N (Row %), 2015 (Based on Registry Data)

Table 17: 7MM, Diagnosed Incident Cases of CF, All Ages, Both Sexes, N, Selected Years 2015–2025 (Adjusted for Underestimation)

Table 18: 7MM, Sex-Specific Diagnosed Incident Cases of CF, All Ages, N (Row %), 2015 (Adjusted for Underestimation)

Table 19: 7MM, Diagnosed Prevalent Cases of CF, All Ages, Both Sexes, N, Selected Years 2015–2025 (Adjusted for Underestimation)

Table 20: 7MM, Age-Specific Diagnosed Prevalent Cases of CF, Both Sexes, N (Row %), 2015 (Adjusted for Underestimation)

Table 21: 7MM, Sex-Specific Diagnosed Prevalent Cases of CF, All Ages, N (Row %), 2015 (Adjusted for Underestimation)

Table 22: 7MM, Diagnosed Prevalent Cases of CF with Chronic MRSA Infection, All Ages, Both Sexes, N, Selected Years 2015–2025 (Adjusted for Underestimation)

Table 23: 7MM, CF Deaths, All Ages, Both Sexes, N, Selected Years 2015–2025 (Adjusted for Underestimation)

Table 24: 7MM, Sex-Specific CF Deaths, All Ages, N (Row %), 2015 (Adjusted for Underestimation)

Table 25: High-Prescribing Physicians (Non-KOLs), Surveyed by Country, 2016

Figure 1: 7MM, Diagnosed Incident Cases of CF, All Ages, Both Sexes, N, 2015 and 2025 (Forecast Based on Registry Data)

Figure 2: 7MM, Diagnosed Prevalent Cases of CF, All Ages, Both Sexes, N, 2015 and 2025 (Forecast Based on Registry Data)

Figure 3: 7MM, CF Deaths, All Ages, Both Sexes, N, 2015 and 2025 (Forecast Based on Registry Data)

Figure 4: 7MM, Diagnosed Incident Cases of CF, All Ages, Both Sexes, N, 2015 and 2025 (Forecast Adjusted for Underestimation)

Figure 5: 7MM, Diagnosed Prevalent Cases of CF, All Ages, Both Sexes, N, 2015 and 2025 (Forecast Adjusted for Underestimation)

Figure 6: 7MM, CF Deaths, All Ages, Both Sexes, N, 2015 and 2025 (Forecast Adjusted for Underestimation)

Figure 7: 7MM, Diagnosed Incident Cases of CF, All Ages, Both Sexes, N, 2015–2025 (Based on Registry Data)

Figure 8: 7MM, Sex-Specific Diagnosed Incident Cases of CF, All Ages, N, 2015 (Based on Registry Data)

Figure 9: 7MM, Diagnosed Prevalent Cases of CF, All Ages, Both Sexes, N, Selected Years 2015–2025 (Based on Registry Data)

Figure 10: 7MM, Age-Specific Diagnosed Prevalent Cases of CF, Both Sexes, N, 2015 (Based on Registry Data)

Figure 11: 7MM, Sex-Specific Diagnosed Prevalent Cases of CF, All Ages, N, 2015 (Based on Registry Data)

Figure 12: 7MM, Age-Standardized Diagnosed Prevalence of CF, All Ages, N, 2015 (Based on Registry Data)

Figure 13: 7MM, Diagnosed Prevalent Cases of CF with Specific Mutations, Both Sexes, All Ages, N, 2015 (Based on Registry Data)

Figure 14: 7MM, Diagnosed Prevalent Cases of CF with Chronic MRSA Infection, Both Sexes, All Ages, N, 2015 (Based on Registry Data)

Figure 15: 7MM, CF Deaths, All Ages, Both Sexes, N, Selected Years 2015–2025 (Based on Registry Data)

Figure 16: 7MM, Sex-Specific CF Deaths, All Ages, N, 2015 (Based on Registry Data)

Figure 17: 7MM, Diagnosed Incident Cases of CF, All Ages, Both Sexes, N, 2015–2025 (Adjusted for Underestimation)

Figure 18: 7MM, Sex-Specific Diagnosed Incident Cases of CF, All Ages, N, 2015 (Adjusted for Underestimation)

Figure 19: 7MM, Diagnosed Prevalent Cases of CF, All Ages, Both Sexes, N, Selected Years 2015–2025 (Adjusted for Underestimation)

Figure 20: 7MM, Age-Specific Diagnosed Prevalent Cases of CF, Both Sexes, N, 2015 (Adjusted for Underestimation)

Figure 21: 7MM, Sex-Specific Diagnosed Prevalent Cases of CF, All Ages, N, 2015 (Adjusted for Underestimation)

Figure 22: 7MM, Diagnosed Prevalent Cases of CF with Specific Mutations, Both Sexes, All Ages, N, 2015 (Adjusted for Underestimation)

Figure 23: 7MM, Diagnosed Prevalent Cases of CF with Chronic MRSA Infection, Both Sexes, All Ages, N, 2015 (Adjusted for Underestimation)

Figure 24: 7MM, CF Deaths, All Ages, Both Sexes, N, Selected Years 2015–2025 (Adjusted for Underestimation)

Figure 25: 7MM, Sex-Specific CF Deaths, All Ages, N, 2015 (Adjusted for Underestimation)